KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jazz Pharmaceuticals (JAZZ) Total Current Liabilities (2016 - 2025)

Historic Total Current Liabilities for Jazz Pharmaceuticals (JAZZ) over the last 16 years, with Q3 2025 value amounting to $2.3 billion.

  • Jazz Pharmaceuticals' Total Current Liabilities rose 12079.15% to $2.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $2.3 billion, marking a year-over-year increase of 12079.15%. This contributed to the annual value of $1.0 billion for FY2024, which is 3241.5% down from last year.
  • Jazz Pharmaceuticals' Total Current Liabilities amounted to $2.3 billion in Q3 2025, which was up 12079.15% from $2.1 billion recorded in Q2 2025.
  • Jazz Pharmaceuticals' Total Current Liabilities' 5-year high stood at $2.3 billion during Q3 2025, with a 5-year trough of $705.4 million in Q2 2022.
  • Over the past 5 years, Jazz Pharmaceuticals' median Total Current Liabilities value was $945.3 million (recorded in 2023), while the average stood at $1.2 billion.
  • As far as peak fluctuations go, Jazz Pharmaceuticals' Total Current Liabilities crashed by 3453.52% in 2024, and later surged by 12079.15% in 2025.
  • Over the past 5 years, Jazz Pharmaceuticals' Total Current Liabilities (Quarter) stood at $809.3 million in 2021, then rose by 15.31% to $933.2 million in 2022, then surged by 64.67% to $1.5 billion in 2023, then tumbled by 32.42% to $1.0 billion in 2024, then skyrocketed by 118.96% to $2.3 billion in 2025.
  • Its Total Current Liabilities stands at $2.3 billion for Q3 2025, versus $2.1 billion for Q2 2025 and $1.2 billion for Q1 2025.